Asma Guardian App for Childhood Asthma

N/A

Recruiting

Led By Elizabeth Matsui, MD

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the use of a special asthma app called Asma Guardián for Hispanic/Latinx children with asthma to the usual care they receive.

Who is the study for?

This trial is for Hispanic/Latinx parents with a child aged 5-12 who has asthma, uses long-term control medication, or meets criteria for persistent disease. The child must have had nocturnal symptoms and an exacerbation in the past year. Families need tech access for the app-based study but can't join if involved in another asthma study.

What is being tested?

The Asthma Guardian trial tests a culturally tailored app designed to help manage childhood asthma against usual care. Participants are randomly assigned to either get immediate access to the Asma Guardian app or receive delayed access after the study period.

What are the potential side effects?

Since this intervention involves using an educational website/app rather than medication, direct side effects are not anticipated. However, there may be indirect consequences related to misinterpretation of information or technology-related issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Participant engagement with the Asthma Guardian website/app

Other study objectives

Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM)

Asthma Control Test (ACT)

Asthma Exacerbation

+15 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: No Access to Asma Guardian website/app for 6 monthsExperimental Treatment1 Intervention

Note: Participants who are randomized to no access will not receive access during the 6 months of the study; however they will receive 1 month of access after their 6 month study visit but any information gained during this time will not be part of analysis.

Group II: Access to Asma Guardian website/appActive Control1 Intervention

Participants who are randomized to the Asma Guardian website at their baseline visit will have access to the website for 6 months starting at baseline. Access will be turned off at 6 months.

Do I qualify?Apply below to find out